Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02170727
Brief Title: A Phase 3 Study of a Daclatasvir/Asunaprevir/BMS-791325 Fixed Dose Combination (FDC) in Subjects With Chronic Hepatitis C Genotype 1 (UNITY 4)

First Submitted : June 20, 2014
First Submitted that Met QC Criteria : June 20, 2014
First Posted : June 23, 2014 (Estimate)

Results First Submitted : March 22, 2019
Results First Submitted that Met QC Criteria : July 9, 2019
Results First Posted : August 16, 2019

Certification/Extension First Submitted : March 22, 2017
Certification/Extension First Submitted that Met QC Criteria : March 22, 2017
Certification/Extension First Posted : March 23, 2017

Last Update Submitted that Met QC Criteria : October 27, 2020
Last Update Posted : October 29, 2020